Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case ‐control study
ConclusionsICHs during VKA therapy preferentially occur in very elderly patients. The risk of ICH is not predicted by the commonly used risk scores. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - September 12, 2018 Category: Cardiology Authors: Luca Zanella,
Giacomo Zoppellaro,
Lucia Marigo,
Gentian Denas,
Seena Padayattil Jose,
Vittorio Pengo Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Lipid ‐lowering therapy with PCSK9‐inhibitors in the real‐world setting: Two‐year experience of a regional lipid clinic
ConclusionsPatient selection by a regional lipid clinic resulted in a high real ‐world PCSK9i insurance approval, with efficacy and safety comparable to randomized clinical trials. Cost and medication nonadherence are potential barriers to successful implementation of therapy in routine clinical care. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - September 12, 2018 Category: Cardiology Authors: Barak Zafrir,
Ayman Jubran Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Issue Information
Cardiovascular Therapeutics,Volume 36, Issue 5, October 2018. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - September 12, 2018 Category: Cardiology Source Type: research
Evidence ‐based pharmacotherapies used in the postdischarge phase are associated with improved one‐year survival in senior patients hospitalized with heart failure
ConclusionsIn a cohort of senior patients hospitalized with HF, dispensing of a RASI or β‐blocker within 60 days postdischarge is associated with a 1‐year survival benefit. Early postdischarge support programs after recent HF hospitalization should include measures to optimize adherence to evidence‐based medications. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - September 11, 2018 Category: Cardiology Authors: Xiwen Qin,
Joseph Hung,
Matthew Knuiman,
Tiew ‐Hwa K. Teng,
Tom Briffa,
Frank M. Sanfilippo Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats
Cardiovascular Therapeutics,Volume 0, Issue ja, -Not available-. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - September 11, 2018 Category: Cardiology Authors: Kai Zhang
,
Zuowang Ma
,
Weiding Wang
,
Ruimeng Liu
,
Yue Zhang
,
Meng Yuan
,
Guangping Li Source Type: research
Evidence ‐based pharmacotherapies used in the postdischarge phase are associated with improved one‐year survival in senior patients hospitalized with heart failure
Cardiovascular Therapeutics, EarlyView. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - September 11, 2018 Category: Cardiology Authors: Xiwen
Qin
,
Joseph
Hung
,
Matthew
Knuiman
,
Tiew ‐Hwa K.
Teng
,
Tom
Briffa
,
Frank M.
Sanfilippo Source Type: research
Use of Acetazolamide in the Treatment of Patients with Refractory Congestive Heart Failure
Cardiovascular Therapeutics,Volume 0, Issue ja, -Not available-. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - September 7, 2018 Category: Cardiology Authors: Julio N úñez
,
Raquel Heredia
,
Ana Payá
,
Ignacio Sanchis
,
Susana del Prado
,
Gema Miñana
,
Enrique Santas
,
Rafael de la Espriella
,
Eduardo Núñez
,
Juan Sanchis
,
Antoni Bayés‐Genís Source Type: research
Effect of evidence ‐based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry
ConclusionsAmong patients discharged after an ACS event, concurrent EBM prescribing was associated with lower all ‐cause mortality that persists for up to 12‐months posthospital discharge. The relative benefits of EBMs were also consistent across age, GRACE risk score, and discharge diagnosis. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - August 28, 2018 Category: Cardiology Authors: Ibrahim Al ‐Zakwani,
Mohammad Zubaid,
Alawi A. Alsheikh‐Ali,
Wael Almahmeed,
Wafa Rashed Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Evidence ‐based pharmacotherapies used in the post‐discharge phase are associated with improved one‐year survival in senior patients hospitalised with heart failure
Cardiovascular Therapeutics,Volume 0, Issue ja, -Not available-. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - August 20, 2018 Category: Cardiology Authors: Xiwen Qin
,
Joseph Hung
,
Matthew Knuiman
,
Tiew ‐Hwa Katherine Teng
,
Tom Briffa
,
Frank M Sanfilippo Source Type: research
Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary intervention
Cardiovascular Therapeutics, EarlyView. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - August 14, 2018 Category: Cardiology Authors: Pei
Zhu
,
Xiaofang
Tang
,
Jingjing
Xu
,
Ying
Song
,
Ru
Liu
,
Yin
Zhang
,
Lijian
Gao
,
Zhan
Gao
,
Jue
Chen
,
Yuejin
Yang
,
Runlin
Gao
,
Bo
Xu
,
Jinqing
Yuan Source Type: research
Effect of evidence ‐based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry
Cardiovascular Therapeutics,Volume 0, Issue ja, -Not available-. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - August 6, 2018 Category: Cardiology Authors: Ibrahim Al ‐Zakwani
,
Mohammad Zubaid
,
Alawi A. Alsheikh‐Ali
,
Wael Almahmeed
,
Wafa Rashed Source Type: research
TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic and pressure induced stress in mice
Cardiovascular Therapeutics,Volume 0, Issue ja, -Not available-. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - August 2, 2018 Category: Cardiology Authors: Zeena Eblimit
,
Sundararajah Thevananther
,
Saul. J. Karpen
,
Heinrich Taegtmeyer
,
David D. Moore
,
Luciano Adorini
,
Daniel J. Penny
,
Moreshwar S. Desai Source Type: research
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta ‐analysis
Cardiovascular Therapeutics, EarlyView. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - July 31, 2018 Category: Cardiology Authors: Zhen
Ge
,
Michela
Faggioni
,
Usman
Baber
,
Samantha
Sartori
,
Sabato
Sorrentino
,
Serdar
Farhan
,
Jaya
Chandrasekhar
,
Birgit
Vogel
,
Abdul
Qadeer
,
Jonathan
Halperin
,
Vivek
Reddy
,
Srinivas
Dukkipati
,
Geo Source Type: research
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case ‐control study
Cardiovascular Therapeutics, EarlyView. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - July 31, 2018 Category: Cardiology Authors: Luca
Zanella
,
Giacomo
Zoppellaro
,
Lucia
Marigo
,
Gentian
Denas
,
Seena
Padayattil Jose
,
Vittorio
Pengo Source Type: research
Vascular Endothelial Growth Factor Gene Transfer Therapy for Coronary Artery Disease: A Systematic Review and Meta ‐Analysis
Cardiovascular Therapeutics,Volume 0, Issue ja, -Not available-. (Source: Cardiovascular Therapeutics)
Source: Cardiovascular Therapeutics - July 23, 2018 Category: Cardiology Authors: Rong Yuan
,
Qiqi Xin
,
Weili Shi
,
Wei Liu
,
Simon ‐M Lee
,
Puiman Hoi
,
Lin Li
,
Jun Zhao
,
Weihong Cong
,
Keji Chen Source Type: research
